Clinical Trials Directory

Trials / Unknown

UnknownNCT03141112

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

The Benefits of Early Initiation of Continuous Renal Replacement Therapy (CRRT) in Patients With Severe Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Radovan Uvizl · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will evaluate the benefit of early initiation of CRRT in the initial phase of severe sepsis in patients admitted to the ICU. Primary evaluated end-point is 28-day mortality. Secondarily evaluated end-point is length of ICU-stay, length of stay in hospital, duration of mechanical ventilation. There are two groups. One group of participants with early CRRT initiation and another group with late CRRT initiation. Reference group no CRRT.

Detailed description

The aim is to determine the optimal timing of initiation of CRRT with respect to the degree and duration of acute kidney injury (AKI) in ICU patients. The CRRT parameters and the duration of therapy will be monitored, depending on initial biochemical and clinical values of the patient. Part of the study is the follow-up of patients with a 3-month delay.

Conditions

Interventions

TypeNameDescription
PROCEDURErenal replacement therapy

Timeline

Start date
2016-08-01
Primary completion
2018-12-01
Completion
2020-12-01
First posted
2017-05-04
Last updated
2017-05-04

Source: ClinicalTrials.gov record NCT03141112. Inclusion in this directory is not an endorsement.